Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 37%
Buy 58%
Hold 5%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare is positioned for strong growth in the coming years, with a potential 10% sequential increase in EBITDA in the first quarter of 2026 and significant potential for organic growth. The company is generating a large amount of cash, with potential for close to 50% of its market cap in the next three years. While there are potential headwinds, such as the expiration of HIX subsidies, Tenet has put itself in a strong position through its business transformation, deleveraging, and performance.

Bears say

Tenet Healthcare is facing cost reduction initiatives, minimal organic growth, and dependence on higher margin USPI business, which raises concerns about its financial stability and competitiveness in a changing healthcare industry. Additionally, the deferral of revenue and high levels of M&A activity also pose risk. While the company may benefit from favorable industry trends, it may face challenges in achieving sustained growth and profitability.

Tenet Healthcare (THC) has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 58% recommend Buy, 5% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 19 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $238.21, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $238.21, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.